Market Access USA Workshop
Market Access USA Workshop by Elizabeth Jennings, Venture Atlas Labs, Austin, TX
Date: 19.8.2025
Time: 9.00–16.00
Venue: Fokus Meeting Room, KPY Novapolis, Microkatu 1, H-part, Kuopio.
Price: 200€ (VAT 0%)
- US market fundamentals: procurement, pricing, insurance, reimbursement, and regulatory pathways
- Investment readiness: engaging US investors, due diligence, pitch practice, and alternative funding
- Commercialization strategy: revenue pre-FDA, sales models, pricing, partnerships, and market adaptation
- Strategic risk management: tools for navigating uncertainty and hedging risk in healthcare development
Please register by 12.8.2025 at 12 noon.
To help you get even more value, we’re offering you the opportunity to bring one colleague from your organization at a special price of 100€.
🔹 Maximum two participants per organization
🔹 You’ll receive a promo code for the second ticket after your first ticket purchase is confirmed
If you’ve already bought your ticket, we’ll be in touch shortly with the promo code you can share with your colleague.
The workshop fee includes morning and afternoon coffee.
Lunch is not included and is at the participant’s own expense.
Agenda:
9:00 – 10:30 | How US healthcare systems value (and buy) innovation
10:30 – 10:45 | Break
10:45 – 12:00 | Aligning your value proposition with health economics
12:00 – 12:45 | Lunch break
12:45 – 2:30 | Commercialization: winning within your runway
2:30 – 2:45 | Break
2:45 – 4:00 | Uncertainty, risk, and research: Practical actions for your next steps
4:00 – | Q&A and open discussion
Join us for an intensive workshop on US market commercialization for healthcare scaleups. This day is structured to provide precisely what you need to know to think for yourself about your commercial opportunities with leading insights from Venture Atlas Labs, which specialises exclusively in helping international healthcare companies succeed in the US.
The US healthcare systems are complicated and varied–but you’ll leave understanding how it works and how it can work to your advantage. Uniquely developed to provide Finnish companies the insights specific to highlight their commercial advantages (and avoid expensive landmines), you’ll get clarity on:
- Why the traditional US healthcare model doesn’t know how to properly value (most) Finnish healthtech innovation–and how to look at different models instead
- How to tell if a facility has the kind of model that allows them to put a price (and budget) on your product
- Why focusing on Reimbursement is so common, the two other arguments you need for adoption, and what to do before you have Reimbursement secured
- How commercialization really works and how to develop commercial scenarios that work for your business and runway
- What is happening in the US right now and objectively looking at your options
- The secret advantage you have in fundraising from US investors
We’ll work a real-world case study, discuss how your individual business fits into the US, and conclude with sparring.
Who this workshop will particularly benefit entrepreneurs, as well as researchers considering commercial opportunities and academic leaders advising researchers, in:
- Medtech, medical devices, and diagnostics
- Digital health and digital therapeutics
- Data and software
Participants will also each receive one free sparring session following the workshop with Venture Atlas Labs (250€ fee waived) available through 2025.
I: 1.5 hours – How US health systems value (and buy) innovation
- Overview of the US landscape and the spectrum of economic models
- Different ecosystem players and their roles
- The three fundamental value propositions: revenue generation or cost reduction,
Relative Value Units (RVUs) and efficiency, and quality outcomes–and the basics of how these are financially calculated in different models in the US
- Fee-for-service vs value-based care: understanding which model rewards your product the most for actual adoption
II: 1.25 hours – Aligning your value proposition with health economics
- How money moves, who gets paid, and how all that is calculated
- Evaluating profit margins and pricing across different health systems and models
- Capitation, profit-sharing, and risk sharing
III: 1.75 hours – Commercialization: winning within your runway
- Value analysis committees, service lines, and stakeholders
- Group purchasing organizations, sales agents, and distributors
- Strategic partnerships and working with OEMs
- Who actually has budget influence: Key Opinion Leaders, scientific advisory boards, and
clinical liaisons
- Developing and evaluating commercial scenarios: strategic planning
- What not to do: the good, the bad, and the orange (jumpsuit)
IV: 1.25 hours – Uncertainty, risk, and research: Practical actions for your next steps
- What the health is going on in the US right now? Thinking about tariffs and funding
- Practical framework for addressing uncertainty with incomplete information
- Pressure testing hypotheses
- Decision-making criteria and the market research that matters
- The secret to fundraising from US investors